Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01
GlobeNewswire
STAFFORD, Texas, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage..
STAFFORD, Texas, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage..
Lakewood, CO, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Centura Health, the Colorado and western Kansas region's leading health care..
Dublin, May 07, 2021 (GLOBE NEWSWIRE) -- The "Connected / Smart Drug Delivery Systems Market by Product Type, Therapeutic Area..